Kamada (KMDA) Net Margin (2012 - 2026)

Kamada (KMDA) reported Net Margin of 9.13% for Q1 2026, down 1191.0% on a YoY basis from 0.84% in Q1 2025, and down 30.91% quarter-over-quarter from 13.22% in Q4 2025.

Kamada (KMDA) Net Margin (2012 - 2026) Analysis & Trends

Kamada has reported Net Margin for 15 years, with the latest figure at 9.13% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 1191.0% year-over-year to 9.13%; the trailing twelve-month figure through Mar 2026 stood at 0.04% (changed 0.0% YoY), and the FY2025 full-year result was 14.82%, up 723.0% from the prior year.
  • Net Margin for Q1 2026 stood at 9.13%, down from 13.22% in the prior quarter.
  • The five-year high for Net Margin was 21.04% in Q1 2025, with the low at 16.62% in Q2 2022.
  • Historically, Net Margin has averaged 5.77% across 5 years, with a median of 6.66% in 2024.
  • Annual changes were most pronounced in 2022 — Net Margin sank 2049 bps — and 2023, when it soared 2153 bps.
  • Kamada's Net Margin stood at 6.48% in 2022, then jumped by 114 bps to 13.88% in 2023, then decreased by 30 bps to 9.76% in 2024, then surged by 35 bps to 13.22% in 2025, then tumbled by 31 bps to 9.13% in 2026.
  • The last three Net Margin figures came in at 9.13% (Q1 2026), 13.22% (Q4 2025), and 17.96% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 9.19%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 26.57%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 35.18%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 2.94%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 24.30%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 4.16%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -168.42%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 31.38%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -15.15%
10 Kamada 505.05 -73.15 Mn 19.12 Mn 9.13%

Historic Data

Download Data
DateValue
Mar 31, 2026 9.13%
Dec 31, 2025 13.22%
Sep 30, 2025 17.96%
Jun 30, 2025 0.00%
Mar 31, 2025 21.04%
Dec 31, 2024 9.76%
Sep 30, 2024 9.66%
Jun 30, 2024 0.00%
Mar 31, 2024 6.66%
Dec 31, 2023 13.88%
Sep 30, 2023 8.50%
Jun 30, 2023 4.91%
Mar 31, 2023 0.00%
Dec 31, 2022 6.48%
Sep 30, 2022 0.00%
Jun 30, 2022 -16.62%
Mar 31, 2022 -6.51%
Dec 31, 2021 -14.82%
Sep 30, 2021 -3.67%
Jun 30, 2021 3.87%